New York-based MindMed has applied for a Nasdaq up-listing and the company is valued at $190 million.
New data reveal that taking psychedelics may impact users in a way similar to having a mystical or religious experience.
Psychedelic drugs could soon have a standardized, and much faster delivery method with the announcement made from ATAI Life Sciences AG and IntelGenx.
A first of its kind, The Psychedelic Medicine Association (PMA) is set to launch on September 29th.
Psychedelics are now bringing another long-term scenario: big-time investments.
The Ann Arbor City Council voted this week to decriminalize psychedelic substances
With anonymous seed funding of $1.25 million, UC Berkeley will begin to conduct research using psychedelics to investigate cognition, perception, and emotion.
Older adults are now moving toward using psychedelics and cannabis as a way to treat illnesses at an affordable cost.